UK's 10-year renal care plans get mixed reception
This article was originally published in Clinica
The UK's blueprint for the development of renal services over the next decade has been received with mixed feelings. The Royal College of Physicians (RCP) and the Renal Association (RA) welcomed the launch of the "badly needed" National Service Framework for Renal Services, but warned that the "lack of specific milestones for delivering the programme could prove a grave mistake".
You may also be interested in...
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.